Kohl's Slashes Dividend by 93.75% Amidst Sales Decline and Cautious Outlook
KSS has more than doubled off its 52-week low of $6.04.
Summary
Kohl's reported a 4.0% net sales decrease for fiscal year 2025 and projected flat to negative 2% sales for 2026, alongside a drastic 93.75% reduction in its quarterly dividend to $0.125 per share.
Key Events · Earnings and Guidance · KSS
-
Significant Dividend Cut
The quarterly cash dividend was reduced from $2.00 per share in fiscal year 2024 to $0.125 per share for Q4 2025, representing a 93.75% reduction.
-
Fiscal Year 2025 Performance
Net sales decreased 4.0% to $14.8 billion, with comparable sales down 3.1%. GAAP net income increased to $272 million, significantly boosted by a $129 million legal settlement.
-
Fiscal Year 2026 Outlook
The company projects net sales and comparable sales to be flat to down 2%, with adjusted diluted EPS anticipated between $1.00 and $1.60.
-
Debt and Liquidity Management
Kohl's issued $360 million in 10.000% senior secured notes due 2030, repaid $353 million of maturing notes, and reduced revolving credit facility borrowings to zero. Credit ratings were downgraded by Moody's and S&P.
Analysis · KSS · Trade & Services
The substantial 93.75% dividend cut is a critical negative signal, indicating significant financial pressure and a shift in capital allocation priorities away from shareholder returns. While the sales decline and cautious 2026 outlook were largely anticipated from a prior 8-K, this annual report confirms the full financial details and the severity of the dividend reduction. The issuance of high-yield secured notes and credit rating downgrades further highlight the company's challenging financial position. Investors should be concerned about the company's ability to stabilize sales and improve profitability in a highly competitive retail environment, especially given the reduced shareholder returns.
At the time of this filing, KSS was trading at $12.85 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $6.04 to $25.22. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.